Common data determinants of recurrent cancer are broken, mislead researchers
Algorithms designed to find patients with recurrent cancer within patient databases don't work
2013-01-03
(Press-News.org) In order to study the effectiveness or cost effectiveness of treatments for recurrent cancer, you first have to discover the patients in medical databases who have recurrent cancer. Generally studies do this with billing or treatment codes – certain codes should identify who does and does not have recurrent cancer. A recent study published in the journal Medical Care shows that the commonly used data determinants of recurrent cancer may be misidentifying patients and potentially leading researchers astray.
"For example, a study might look in a database for all patients who had chemotherapy and then another round of chemotherapy more than six months after the first, imagining that a second round defines recurrent disease. Or a study might look in a database for all patients with a newly discovered secondary tumor, imagining that all patients with a secondary tumor have recurrent disease. Our study shows that both methods are leave substantial room for improvement," says Debra Ritzwoller, PhD, health economist at the Kaiser Permanente Colorado Institute for Health Research and investigator at the University of Colorado Cancer Center.
The study used two unique datasets derived from HMO/Cancer Research Network and CanCORS/Medicare to check if the widely used algorithms in fact discovered the patients with recurrent disease that the algorithms were designed to detect. They did not. For example, a newly diagnosed secondary cancer may not mark a recurrence but may instead be a new cancer entirely; a second, later round of chemotherapy may be needed for continuing control of the de novo cancer, and not to treat recurrence.
"Basically, these algorithms don't work for all cancer sites in many datasets commonly used for cancer research," says Ritzwoller.
For example, to discover recurrent prostate cancer, no combination of billing codes used in this large data set pointed with sensitivity and specificity to patients whom notes in the data showed had recurrent disease. The highest success of the widely used algorithms was predicting patients with recurrent lung, colorectal and breast cancer, with success rates only between 75 and 85 percent.
"We need to know who in these data sets has recurrent disease. Then we can do things like look at which treatments lead to which outcomes," Ritzwoller says. Matching patients to outcomes can help to decide who gets what treatment, and can help optimize costs in health care systems.
In a forthcoming paper, Ritzwoller and colleagues will suggest algorithms to replace these that have now proved inadequate.
INFORMATION: END
ELSE PRESS RELEASES FROM THIS DATE:
2013-01-03
Following a three-year study using more than 2,800 mice, a University of Missouri researcher was not able to replicate a series of previous studies by another research group investigating the controversial chemical BPA. The MU study is not claiming that BPA is safe, but that the previous series of studies are not reproducible. The MU study, published in the Proceedings of the National Academy of Sciences, also investigated an estrogenic compound found in plants, genistein, in the same three-year study.
"Our findings don't say anything about the positive or negative effects ...
2013-01-03
This press release is available in Spanish.
U.S. Department of Agriculture (USDA) scientists are developing strategies to help livestock producers control stable flies, the most damaging arthropod pests of cattle in the United States.
An economic impact assessment by scientists at the Agricultural Research Service (ARS) Agroecosystem Management Research Unit (AMRU) in Lincoln, Neb., looked at four sectors of cattle production: dairy, cow/calf, pastured and range stocker, and animals on feed. They found that stable flies cost the U.S. cattle industry more than $2.4 ...
2013-01-03
A new ray of hope has broken through the clouded outcomes associated with Alzheimer's disease. A new research report published in January 2013 print issue of the FASEB Journal by scientists from the National Institutes of Health shows that when a molecule called TFP5 is injected into mice with disease that is the equivalent of human Alzheimer's, symptoms are reversed and memory is restored—without obvious toxic side effects.
"We hope that clinical trial studies in AD patients should yield an extended and a better quality of life as observed in mice upon TFP5 treatment," ...
2013-01-03
BOSTON – A small percentage of men in a prostate cancer study complained that their penis seemed shorter following treatment, with some saying that it interfered with intimate relationships and caused them to regret the type of treatment they chose.
Complaints were more common in men treated with radical prostatectomy (surgical removal of the prostate) or male hormone-blocking drugs combined with radiation therapy, according to the study by researchers from Dana-Farber/Brigham and Women's Cancer Center (DF/BWCC). No men reported a perceived shortening of their penis following ...
2013-01-03
In Ethiopia, where more than 1.2 million people are infected with HIV, disclosure of infection by patients is important in the fight against the disease. A new study led by a Brown sociology researcher investigates HIV-positive status disclosure rates among men and women in Africa's second most populous country.
In the December 17 issue of AIDS Care, Ayalu Reda, a sociology graduate student, and colleagues from Jimma University in Ethiopia found that among a sample of 1,540 patients receiving antiretroviral treatment in eastern Ethiopia, a majority (66 percent) disclosed ...
2013-01-03
Alexandria, VA – The Burgess Shale provides us with a rare glimpse into the softer side of paleontology. Most fossils are preserved hard parts – bones, teeth and shells – but one of the most famous fossil locales in the world, the Burgess Shale, reveals subtle soft body structures like gills and eyes delicately preserved between the layers of dark rock. For more than 100 years, the Burgess Shale has been giving us a unique perspective on what life was like in the Cambrian seas. This month, EARTH Magazine contributor Mary Caperton Morton reminds us that no matter how well ...
2013-01-03
MAYWOOD, Il. - Millions of Americans read physician ratings on websites such as Healthgrades.com, but such ratings are based on scores from an average of only 2.4 patients, a Loyola University Medical Center study has found.
The study of 500 randomly selected urologists found that 79.6 percent of physicians were rated by at least one of the 10 free physician-review websites researchers examined. Eighty-six percent of physicians had positive ratings, with 36 percent receiving highly positive ratings. Healthgrades had the most physician ratings.
Results were published ...
2013-01-03
Today, mothers of newborns find themselves confronting a common dilemma: Should they let their babies "cry it out" when they wake up at night? Or should they rush to comfort their crying little one?
In fact, waking up in the middle of the night is the most common concern that parents of infants report to pediatricians. Now, a new study from Temple psychology professor Marsha Weinraub gives parents some scientific facts to help with that decision.
The study, published in Developmental Psychology, supports the idea that a majority of infants are best left to self-soothe ...
2013-01-03
Athens, Ga. – Why do girls get better grades in elementary school than boys—even when they perform worse on standardized tests?
New research from the University of Georgia and Columbia University published in the current issue of Journal of Human Resources suggests that it's because of their classroom behavior, which may lead teachers to assign girls higher grades than their male counterparts.
"The skill that matters the most in regards to how teachers graded their students is what we refer to as 'approaches toward learning,'" said Christopher Cornwell, head of economics ...
2013-01-03
CAMBRIDGE, MA -- Almost all computer chips use two types of transistors: one called p-type, for positive, and one called n-type, for negative. Improving the performance of the chip as a whole requires parallel improvements in both types.
At the IEEE's International Electron Devices Meeting (IEDM) in December, researchers from MIT's Microsystems Technology Laboratories (MTL) presented a p-type transistor with the highest "carrier mobility" yet measured. By that standard, the device is twice as fast as previous experimental p-type transistors and almost four times as fast ...
LAST 30 PRESS RELEASES:
[Press-News.org] Common data determinants of recurrent cancer are broken, mislead researchers
Algorithms designed to find patients with recurrent cancer within patient databases don't work
